USPTO serial 97442977
BIONOTE
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Dec 3, 2024
- Examiner
- WOLD, BARBARA NIELSEN
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with BIONOTE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Gyeonggi-do, KR
Gyeonggi-do, KR
Gyeonggi-do, KR
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
CHANGHOON LEE
302 GANGNAM-DAERO, GANGNAM-GU10-14TH FLOOR, DONGHEE BUILDINGSEOUL, 06253Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 010 | (Based on Use in Commerce) Medical diagnostic apparatus for testing for viruses; home virus test kits consisting primarily of medical diagnostic test strips for saliva or nasal discharge analysis, sampling tools being medical swabs, and buffers for use in disease testing; medical and veterinary apparatus for analyzing bacteria in biological samples; medical genetic fragment analyzers for use in the veterinary field; medical genetic analyzer for use in the veterinary field; real-time gene amplification equipment for medical use in the veterinary field; immunological analyzers for medical and veterinary use; medical immunoassay apparatus for use in the veterinary field; medical diagnostic testing instruments for use in immunoassay procedure for use in the veterinary field; immunofluorescence analysis apparatus for medical purposes in the veterinary field; immunoassay apparatus for medical diagnosis in the veterinary field; miniaturized sensors for use in gene analysis and diagnosis for medical and veterinary purposes; medical apparatus for use in treating respiratory, gastrointestinal disease, tropical disease, viral hepatitis, cardiovascular disease, cancer, cytokine or immunoglobulin for use in the veterinary field; medical and veterinary laboratory instruments, namely, clinical chemistry analyzers for medical and veterinary diagnostic use and immunochemistry analyzers for the analysis of biological samples for medical diagnostic use; medical laboratory instruments for performing polymerase chain reaction (PCR) analysis for medical and veterinary diagnostic use; medical devices for use in performing polymerase chain reaction (PCR) for medical and veterinary diagnostic use; apparatus for use in medical analysis, namely, polymerase chain reaction (PCR) instruments for medical and veterinary diagnostic use; medical diagnostic instruments for the analysis of body fluids; apparatus for use in medical diagnostic antigen tests and antibody tests for determining infection with respiratory disease or HIV; (Based on 44(e)) diabetes measuring apparatus, namely, medical and veterinary test kits for diabetes monitoring for home use; glycated hemoglobin measuring apparatus; medical and veterinary diagnostic apparatus for detecting atherosclerosis; apparatus used in implementing diagnosis tests designed to detect the abnormal prion protein; medical and veterinary diagnostic apparatus for testing for bacteria and viruses; medical and veterinary diagnostic apparatus for testing for viruses in urine; veterinary apparatus and instruments, namely, surgical apparatus and instruments for veterinary use; veterinary apparatus, namely, surgical apparatus and instruments for veterinary use; diagnostic apparatus for the detection of respiratory, gastrointestinal disease, tropical disease, viral hepatitis, cardiovascular disease, cancer, cytokine or immunoglobulin for veterinary use; kidney function test equipment, namely, medical and veterinary diagnostic apparatus for testing kidney functioning; cancer diagnosis measuring apparatus, namely, medical and veterinary apparatus for detecting cancer; genetic testing apparatus for medical and veterinary purposes; electromagnetic medical diagnostic imaging apparatus; genetic testing apparatus for medical purposes; medical ultrasonic diagnostic equipment, namely, medical ultrasound apparatus; pregnancy testing devices, instruments and apparatus, namely, multi-drug testing cups for pregnancy testing purposes; immunoassay apparatus for diagnosis being medical instruments to measure fluorescent immunoassay, serologic test, enzyme-linked immune-specific assay(ELISA), molecular point-of-care (POC) system, automatic blood chemistry analyzer; blood analysis apparatus for diagnosis being medical instruments to measure fluorescent immunoassay, serologic test, enzyme-linked immune-specific assay(ELISA), molecular point-of-care (POC) system, automatic blood chemistry analyzer; ultrasound displaying diagnostic apparatus; devices for measuring blood sugar | ACTIVE | Jan 10, 2020 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Dec 3, 2024 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Dec 3, 2024 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Nov 13, 2024 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | — |
| Nov 13, 2024 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Oct 7, 2024 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Oct 4, 2024 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Aug 2, 2024 | IUAF | USE AMENDMENT FILED | — |
| Aug 2, 2024 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Mar 26, 2024 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jan 30, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jan 30, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jan 10, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Dec 26, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Dec 26, 2023 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Dec 26, 2023 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Dec 26, 2023 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Dec 26, 2023 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Dec 14, 2023 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Jul 18, 2023 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| Jul 5, 2023 | FIXD | ELECTRONIC RECORD REVIEW COMPLETE | — |
| Jun 30, 2023 | ERRR | ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED | — |
| Jun 28, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 28, 2023 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jun 28, 2023 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jun 28, 2023 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jun 28, 2023 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jun 7, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 6, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 6, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 6, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 22, 2023 | XELG | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | — |
| May 22, 2023 | XELR | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | — |
| Feb 27, 2023 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 27, 2023 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 27, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 22, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 14, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 8, 2022 | NWAP | NEW APPLICATION ENTERED | — |